ClinicalTrials.gg
Drug

Ivacaftor clinical trials

Also written VX-770, Kalydeco and VX-561.

studies test it
94
open now
5
in phase 3
45
first study started
2007

Counted the way a researcher would: Ivacaftor with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses ivacaftor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ivacaftor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Jan 2012 · KALYDECO · NDA 203188 (FDA, Drugs@FDA)
European Union
23 Jul 2012 · Kalydeco · EMEA/H/C/002494 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ivacaftor
63
IVA
28
Deutivacaftor
3
D-IVA
3
VX-770, IVA
3

Brand

Kalydeco
13

Development codes

VX-770
50
VX-561
5
CTP-656
4

In one entry with another drug

Given together, or one or the other

elexacaftor/tezacaftor/ivacaftor
15
lumacaftor/ivacaftor
6

Studies by the year they started

94 studies that test it; most in 2016 (12)

Studies that test ivacaftor, by start year
YearStudies
20071
20095
20107
20111
20124
20138
20142
201511
201612
20178
20188
20194
20207
20215
20224
20232
20241
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
16
Phase 2
22
Phase 3
45
Phase 4
8
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 78 · Other 16

Vertex Pharmaceuticals Incorporated (74) · University of Alabama at Birmingham (7) · Concert Pharmaceuticals (3) · Royal College of Surgeons, Ireland (1) · Istituto Auxologico Italiano (1) · Nottingham University Hospitals NHS Trust (1) · Parion Sciences (1) · University of California, San Francisco (1)

Often tested with

Tested in the same studies.

Tezacaftor (39) · Elexacaftor (18) · Lumacaftor (16) · Olacaftor (2) · Ciprofloxacin (2) · VX-828 (1) · Lumacaftor, ivacaftor drug combination (1) · Vanzacaftor (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 2 in phase 3

Studies that test ivacaftor, phase 3 first.

Studies

Open first, then newest update. How each study uses ivacaftor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 94

See all 94 studies that test ivacaftor →

Given beside what is tested · 23 — ivacaftor is usual care or a partner of the new treatment

Showing 20 of 23.

As the comparator · 7 — what is tested is compared with ivacaftor

Codes

What other systems call ivacaftor · ClinicalTrials.gg INT005526

  • MeSH (NLM) C545203ivacaftorConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 1Y740ILL1ZIVACAFTORConfirmed FDA, NLM, Wikidata
  • RxNorm 1243041Confirmed FDA, Wikidata
  • Wikidata Q6095693ivacaftorConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166523IvacaftorOne source FDA
  • DrugBank DB08820One source Wikidata

Also registered as deutivacaftor (UNII SHA6U5FJZL).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.